Drug Treatment of Hyperlipidemias

  • David Kritchevsky

Abstract

Drug treatment of hyperlipidemia has advanced markedly over the last two decades. Whereas earlier efforts were aimed at reduction of either cholesterol or triglyceride levels (usually the former), today drugs are tested for their effects on specific types of hyperlipidemia and on enrichment or depletion of specific lipoprotein fractions.

Keywords

Cholesterol Hydrolysis Phenyl Metformin Triglyceride 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bailey JM (1965) Exp Cell Res 37: 175PubMedCrossRefGoogle Scholar
  2. Barr DP, Russ EM, Eder HA (1951) Am J Med 11: 480PubMedCrossRefGoogle Scholar
  3. Bencze WL (1975) In: Kritchevksy D (ed) Hypolipidemic Agents. Springer-Verlag, Berlin, p 349Google Scholar
  4. Bencze WL (1978) New hypolipidemic drugs. In: Kritchevsky D, Paoletti R, Holmes WL (eds) Drugs, Lipid Metabolism and Atherosclerosis. Plenum Publishing Corp., New York, p 77Google Scholar
  5. Burns CH, Rothblat GH (1969) Biochim Biophys Acta 176: 616PubMedGoogle Scholar
  6. Castelli WP, Doyle JT, Gordon T, Haines C, Hjortland MC, Hulley SB, Kagan A, Zukel WJ (1977) Circulation 55:766Google Scholar
  7. Cayen MN, Dubuc J, Dvornik D (1976) Biochem Pharmacol 25: 1537PubMedCrossRefGoogle Scholar
  8. Fredrickson DS, Lees RS (1965) Circulation 31: 321PubMedGoogle Scholar
  9. Fredrickson DS, Levy RI, Lees RS (1967) New Engl J Med 276: 32, 94, 148, 215, 273Google Scholar
  10. Glueck CJ, Gartside PS, Steiner FM, Miller M, Todhunter T, Haaf J, Pucke M, Terranna M, Fallat RW, Kashyab LML (1977) Atheroscler 27: 387CrossRefGoogle Scholar
  11. Gordon T, Castelli WP, Hjortland MJ, Kannel WB (1977) Am J Med 62: 707PubMedCrossRefGoogle Scholar
  12. Hulley SB (1978) In: Kritchevsky D, Paoletti R, Holmes WL (eds) Drugs, Lipid Metabolism and Atherosclerosis. Plenum Publishing Corp., New York, p 295Google Scholar
  13. Kritchevsky D, Kothari HV (1978) Adv Lipid Res 16: 221PubMedGoogle Scholar
  14. Kritchevsky D, Tepper SA, Kothari HV (1975) Artery 1: 437Google Scholar
  15. Levy RI, Fredrickson DS, Shulman R, Bilheimer DW, Breslow JL, Stone NJ, Lux SE, Sloan HR, Krauss RM, Herbert PN (1972) Ann Int Med 77: 267Google Scholar
  16. Marquié G, Agid R, (1968) C R Soc Biol (Paris) 162: 563Google Scholar
  17. Miller GJ, Miller NE (1975) Lancet 1: 16PubMedCrossRefGoogle Scholar
  18. Paffenbarger RS, Hale WE, Beard RJ, Hyde RT (1977) Am J Epidemiol 105: 2PubMedGoogle Scholar
  19. Pichardo R, Boulet L, Davigno J (1977) Atheroscler 26: 5CrossRefGoogle Scholar
  20. Rhoads GG, Gulbrandsen CL, Kaga A (1976) New Eng J Med 294: 2PubMedCrossRefGoogle Scholar
  21. Rodriguez J, Catapano A, Ghiselli GC, Sirtori CR (1976) In: Day CE (ed) “Atherosclerosis Drug Discovery.” Plenum Publishing Corp., New York, p 169Google Scholar
  22. Rossner S, Or L (1978) In: Kritchevsky D, Paoletti R, Holmes WL (eds) Drugs, Lipid Metabolism and Atherosclerosis. Plenum Publishing Corp., New York, p 40Google Scholar
  23. Rothblat GH, Buchko MK, Kritchevsky D (1968) Biochim Biophys Acta 164: 327PubMedGoogle Scholar
  24. Schurr PE, Day CE (1976) Lipids 12CrossRefGoogle Scholar
  25. Sirtori CR, Catapano A, Ghiselli GC, Innocenti AL, Rodriguez J (1977) Atheroscler 26CrossRefGoogle Scholar
  26. Sirtori CR, Catapano A, Ghiselli GC, Malinow R (1976) Artery 2: 3Google Scholar
  27. Slack J, Noble N, Meade TW, North RS (1977) Br Med J 2: 353PubMedCrossRefGoogle Scholar
  28. Windau A (1910) Z Physiol Chem 67: 174CrossRefGoogle Scholar
  29. Wood PD, Haskell W, Klein H, Lewis S, Stern MP, Farquhar JW (1976) Metabolism 25: 1249PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1980

Authors and Affiliations

  • David Kritchevsky

There are no affiliations available

Personalised recommendations